# Match Group, Inc.: financial statements, quarterly MTCH · Nasdaq · CIK 891103 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/mtch.md) · [Financials](/companies/mtch/financials.md) · [Filings](/companies/mtch/filings.md) · [Insiders](/companies/mtch/insiders.md) Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/mtch/financials.md?period=annual). ## Income statement | Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [882](/filings/0000891103-24-000114.md) | [866 d](/filings/0000891103-26-000025.md) | [860](/filings/0000891103-25-000076.md) | [864](/filings/0000891103-25-000124.md) | [895](/filings/0000891103-25-000180.md) | [860 d](/filings/0000891103-26-000025.md) | [831](/filings/0000891103-26-000073.md) | [864](/filings/0000891103-26-000130.md) | [914](/filings/0000891103-25-000180.md) | [878 d](/filings/0000891103-26-000025.md) | [864](/filings/0000891103-26-000073.md) | [853](/filings/0000891103-26-000130.md) | | Cost of revenue | $m | [256](/filings/0000891103-24-000114.md) | [208 d](/filings/0000891103-26-000025.md) | [257](/filings/0000891103-25-000076.md) | [245](/filings/0000891103-25-000124.md) | [253](/filings/0000891103-25-000180.md) | [236 d](/filings/0000891103-26-000025.md) | [237](/filings/0000891103-26-000073.md) | [242](/filings/0000891103-26-000130.md) | [247](/filings/0000891103-25-000180.md) | [222 d](/filings/0000891103-26-000025.md) | [211](/filings/0000891103-26-000073.md) | [204](/filings/0000891103-26-000130.md) | | Research and development | $m | [94.1](/filings/0000891103-24-000114.md) | [97.6 d](/filings/0000891103-26-000025.md) | [116](/filings/0000891103-25-000076.md) | [114](/filings/0000891103-25-000124.md) | [104](/filings/0000891103-25-000180.md) | [109 d](/filings/0000891103-26-000025.md) | [121](/filings/0000891103-26-000073.md) | [115](/filings/0000891103-26-000130.md) | [105](/filings/0000891103-25-000180.md) | [109 d](/filings/0000891103-26-000025.md) | [117](/filings/0000891103-26-000073.md) | [115](/filings/0000891103-26-000130.md) | | Operating income | $m | [244](/filings/0000891103-24-000114.md) | [260 d](/filings/0000891103-26-000025.md) | [185](/filings/0000891103-25-000076.md) | [205](/filings/0000891103-25-000124.md) | [211](/filings/0000891103-25-000180.md) | [223 d](/filings/0000891103-26-000025.md) | [173](/filings/0000891103-26-000073.md) | [194](/filings/0000891103-26-000130.md) | [221](/filings/0000891103-25-000180.md) | [285 d](/filings/0000891103-26-000025.md) | [236](/filings/0000891103-26-000073.md) | [245](/filings/0000891103-26-000130.md) | | Interest expense | $m | [40.4](/filings/0000891103-23-000114.md) | [40.4 d](/filings/0000891103-24-000014.md) | [40.4](/filings/0000891103-24-000057.md) | [40.0](/filings/0000891103-25-000124.md) | [40.1](/filings/0000891103-25-000180.md) | [39.6 d](/filings/0000891103-26-000025.md) | [35.3](/filings/0000891103-26-000073.md) | [32.2](/filings/0000891103-26-000130.md) | [37.0](/filings/0000891103-25-000180.md) | [43.1 d](/filings/0000891103-26-000025.md) | [42.5](/filings/0000891103-26-000073.md) | [42.4](/filings/0000891103-26-000130.md) | | Income tax | $m | [47.3](/filings/0000891103-24-000114.md) | [(4.8) d](/filings/0000891103-26-000025.md) | [30.6](/filings/0000891103-25-000076.md) | [41.7](/filings/0000891103-25-000124.md) | [41.2](/filings/0000891103-25-000180.md) | [39.3 d](/filings/0000891103-26-000025.md) | [22.4](/filings/0000891103-26-000073.md) | [32.2](/filings/0000891103-26-000130.md) | [32.9](/filings/0000891103-25-000180.md) | [45.1 d](/filings/0000891103-26-000025.md) | [33.7](/filings/0000891103-26-000073.md) | [44.1](/filings/0000891103-26-000130.md) | | Net income | $m | [164](/filings/0000891103-24-000114.md) | [230 d](/filings/0000891103-26-000025.md) | [123](/filings/0000891103-25-000076.md) | [133](/filings/0000891103-25-000124.md) | [136](/filings/0000891103-25-000180.md) | [158 d](/filings/0000891103-26-000025.md) | [118](/filings/0000891103-26-000073.md) | [125](/filings/0000891103-26-000130.md) | [161](/filings/0000891103-25-000180.md) | [210 d](/filings/0000891103-26-000025.md) | [167](/filings/0000891103-26-000073.md) | [171](/filings/0000891103-26-000130.md) | | Diluted EPS | $ per share | [0.57](/filings/0000891103-24-000114.md) | not reported | [0.44](/filings/0000891103-25-000076.md) | [0.48](/filings/0000891103-25-000124.md) | [0.51](/filings/0000891103-25-000180.md) | not reported | [0.44](/filings/0000891103-26-000073.md) | [0.49](/filings/0000891103-26-000130.md) | [0.62](/filings/0000891103-25-000180.md) | not reported | [0.68](/filings/0000891103-26-000073.md) | [0.70](/filings/0000891103-26-000130.md) | | Basic EPS | $ per share | [0.59](/filings/0000891103-24-000114.md) | not reported | [0.46](/filings/0000891103-25-000076.md) | [0.50](/filings/0000891103-25-000124.md) | [0.53](/filings/0000891103-25-000180.md) | not reported | [0.47](/filings/0000891103-26-000073.md) | [0.51](/filings/0000891103-26-000130.md) | [0.67](/filings/0000891103-25-000180.md) | not reported | [0.71](/filings/0000891103-26-000073.md) | [0.73](/filings/0000891103-26-000130.md) | - Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax - Cost of revenue: us-gaap:CostOfGoodsAndServicesSold - Research and development: us-gaap:ResearchAndDevelopmentExpense - Operating income: us-gaap:OperatingIncomeLoss - Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating - Income tax: us-gaap:IncomeTaxExpenseBenefit - Net income: us-gaap:ProfitLoss, us-gaap:NetIncomeLoss - Diluted EPS: us-gaap:EarningsPerShareDiluted - Basic EPS: us-gaap:EarningsPerShareBasic ## Balance sheet | Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Cash and equivalents | $m | [707](/filings/0000891103-24-000114.md) | [862](/filings/0000891103-26-000025.md) | [915](/filings/0000891103-24-000057.md) | [838](/filings/0000891103-24-000095.md) | [856](/filings/0000891103-24-000114.md) | [966](/filings/0000891103-26-000025.md) | [409](/filings/0000891103-25-000076.md) | [335](/filings/0000891103-25-000124.md) | [1,053](/filings/0000891103-25-000180.md) | [1,028](/filings/0000891103-26-000130.md) | [1,020](/filings/0000891103-26-000073.md) | [581](/filings/0000891103-26-000130.md) | | Current assets | $m | [1,118](/filings/0000891103-23-000114.md) | [1,271](/filings/0000891103-25-000027.md) | [1,250](/filings/0000891103-24-000057.md) | [1,286](/filings/0000891103-24-000095.md) | [1,323](/filings/0000891103-24-000114.md) | [1,398](/filings/0000891103-26-000025.md) | [832](/filings/0000891103-25-000076.md) | [770](/filings/0000891103-25-000124.md) | [1,528](/filings/0000891103-25-000180.md) | [1,427](/filings/0000891103-26-000130.md) | [1,422](/filings/0000891103-26-000073.md) | [952](/filings/0000891103-26-000130.md) | | Total assets | $m | [4,249](/filings/0000891103-23-000114.md) | [4,508](/filings/0000891103-25-000027.md) | [4,403](/filings/0000891103-24-000057.md) | [4,369](/filings/0000891103-24-000095.md) | [4,426](/filings/0000891103-24-000114.md) | [4,466](/filings/0000891103-26-000025.md) | [3,890](/filings/0000891103-25-000076.md) | [3,868](/filings/0000891103-25-000124.md) | [4,543](/filings/0000891103-25-000180.md) | [4,461](/filings/0000891103-26-000130.md) | [4,408](/filings/0000891103-26-000073.md) | [4,034](/filings/0000891103-26-000130.md) | | Current liabilities | $m | [570](/filings/0000891103-23-000114.md) | [532](/filings/0000891103-25-000027.md) | [519](/filings/0000891103-24-000057.md) | [512](/filings/0000891103-24-000095.md) | [530](/filings/0000891103-24-000114.md) | [549](/filings/0000891103-26-000025.md) | [512](/filings/0000891103-25-000076.md) | [1,105](/filings/0000891103-25-000124.md) | [1,084](/filings/0000891103-25-000180.md) | [1,007](/filings/0000891103-26-000130.md) | [907](/filings/0000891103-26-000073.md) | [552](/filings/0000891103-26-000130.md) | | Long-term debt | $m | [3,841](/filings/0000891103-23-000114.md) | [3,842](/filings/0000891103-24-000014.md) | [3,844](/filings/0000891103-24-000057.md) | [3,846](/filings/0000891103-24-000095.md) | [3,847](/filings/0000891103-24-000114.md) | [3,849](/filings/0000891103-25-000180.md) | [3,427](/filings/0000891103-25-000076.md) | [2,855](/filings/0000891103-25-000124.md) | [3,548](/filings/0000891103-25-000180.md) | [3,549](/filings/0000891103-26-000025.md) | [3,550](/filings/0000891103-26-000073.md) | [3,552](/filings/0000891103-26-000130.md) | | Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | [0.0](/filings/0000891103-26-000025.md) | not reported | [575](/filings/0000891103-25-000124.md) | [499](/filings/0000891103-25-000180.md) | [424](/filings/0000891103-26-000130.md) | [424](/filings/0000891103-26-000073.md) | [0.0](/filings/0000891103-26-000130.md) | | Shareholders' equity | $m | [(299)](/filings/0000891103-23-000114.md) | [(19.5)](/filings/0000891103-25-000027.md) | [(108)](/filings/0000891103-24-000057.md) | [(130)](/filings/0000891103-24-000095.md) | [(88.5)](/filings/0000891103-24-000114.md) | [(63.7)](/filings/0000891103-26-000025.md) | [(183)](/filings/0000891103-25-000076.md) | [(231)](/filings/0000891103-25-000124.md) | [(224)](/filings/0000891103-25-000180.md) | [(254)](/filings/0000891103-26-000130.md) | [(218)](/filings/0000891103-26-000073.md) | [(237)](/filings/0000891103-26-000130.md) | - Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue - Current assets: us-gaap:AssetsCurrent - Total assets: us-gaap:Assets - Current liabilities: us-gaap:LiabilitiesCurrent - Long-term debt: us-gaap:LongTermDebt, us-gaap:LongTermDebtNoncurrent - Current portion of debt: us-gaap:LongTermDebtCurrent - Shareholders' equity: us-gaap:StockholdersEquity ## Cash flow | Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Operating cash flow | $m | [291 d](/filings/0000891103-24-000114.md) | [276 d](/filings/0000891103-26-000025.md) | [284](/filings/0000891103-25-000076.md) | [129 d](/filings/0000891103-25-000124.md) | [265 d](/filings/0000891103-25-000180.md) | [255 d](/filings/0000891103-26-000025.md) | [193](/filings/0000891103-26-000073.md) | [244 d](/filings/0000891103-26-000130.md) | [321 d](/filings/0000891103-25-000180.md) | [323 d](/filings/0000891103-26-000025.md) | [194](/filings/0000891103-26-000073.md) | [370 d](/filings/0000891103-26-000130.md) | | Capital expenditure | $m | [12.6 d](/filings/0000891103-24-000114.md) | [17.4 d](/filings/0000891103-26-000025.md) | [17.2](/filings/0000891103-25-000076.md) | [12.7 d](/filings/0000891103-25-000124.md) | [13.1 d](/filings/0000891103-25-000180.md) | [7.6 d](/filings/0000891103-26-000025.md) | [15.4](/filings/0000891103-26-000073.md) | [12.9 d](/filings/0000891103-26-000130.md) | [13.8 d](/filings/0000891103-25-000180.md) | [14.7 d](/filings/0000891103-26-000025.md) | [20.4](/filings/0000891103-26-000073.md) | [17.3 d](/filings/0000891103-26-000130.md) | | Dividends paid | $m | not reported | not reported | [0.0](/filings/0000891103-25-000076.md) | [0.0 d](/filings/0000891103-25-000124.md) | [0.0 d](/filings/0000891103-25-000180.md) | [0.0 d](/filings/0000891103-26-000025.md) | [47.8](/filings/0000891103-26-000073.md) | [47.2 d](/filings/0000891103-26-000130.md) | [45.9 d](/filings/0000891103-25-000180.md) | [45.4 d](/filings/0000891103-26-000025.md) | [44.2](/filings/0000891103-26-000073.md) | [46.7 d](/filings/0000891103-26-000130.md) | | Share repurchases | $m | [300 d](/filings/0000891103-24-000114.md) | [101 d](/filings/0000891103-26-000025.md) | [189](/filings/0000891103-25-000076.md) | [199 d](/filings/0000891103-25-000124.md) | [243 d](/filings/0000891103-25-000180.md) | [122 d](/filings/0000891103-26-000025.md) | [189](/filings/0000891103-26-000073.md) | [231 d](/filings/0000891103-26-000130.md) | [130 d](/filings/0000891103-25-000180.md) | [239 d](/filings/0000891103-26-000025.md) | [60.1](/filings/0000891103-26-000073.md) | [185 d](/filings/0000891103-26-000130.md) | - Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities - Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment - Dividends paid: us-gaap:PaymentsOfDividends - Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock ## Shares | Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Diluted shares (weighted) | millions of shares | [300](/filings/0000891103-23-000114.md) | [297](/filings/0000891103-24-000057.md) | [295](/filings/0000891103-24-000095.md) | [293](/filings/0000891103-24-000114.md) | [286](/filings/0000891103-25-000076.md) | [282](/filings/0000891103-25-000124.md) | [276](/filings/0000891103-25-000180.md) | [272](/filings/0000891103-26-000073.md) | [264](/filings/0000891103-26-000130.md) | [260](/filings/0000891103-25-000180.md) | [251](/filings/0000891103-26-000073.md) | [248](/filings/0000891103-26-000130.md) | - Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding Shares outstanding: 229,550,985 at 2026-07-31, from the cover of the [10-Q filed 2026-08-05](/filings/0000891103-26-000130.md) (dei:EntityCommonStockSharesOutstanding). Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:27 ET. No prices; not investment advice.